Gwen A. Melincoff - Director at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gwen A. Melincoff since 10/30/2024

Holdings reported by Gwen A. Melincoff for Protalix BioTherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.5K $11.6K $1.55 Sep 3, 2025 By Trust
Stock Options (Right to Buy) 15K Sep 3, 2025 Direct Common Stock

Transactions reported by Gwen A. Melincoff for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.